Cellectar Biosciences (CLRB) Capital Leases (2010 - 2018)
Cellectar Biosciences (CLRB) posted Capital Leases of $568.0 for Q2 2018, down 59.49% sequentially from $1402.0 in Q1 2018, and down 84.94% YoY from $3772.0 in Q2 2017.
Cellectar Biosciences (CLRB) Capital Leases (2010 - 2018) Analysis & Trends
Cellectar Biosciences has reported Capital Leases for 9 years, with the latest figure at $568.0 in Q2 2018.
- Quarterly Capital Leases fell 84.94% year-over-year to $568.0 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $568.0 (down 84.94% YoY) and the FY2017 annual result came in at $2213.0, down 57.84% from the prior year.
- Capital Leases fell to $568.0 in Q2 2018 per CLRB's latest filing, from $1402.0 in the prior quarter.
- Over five years, Capital Leases peaked at $11184.0 in Q3 2014 and troughed at $568.0 in Q2 2018.
- A 5-year average of $6179.9 and a median of $6303.5 in 2016 frame the typical range for Capital Leases.
- The sharpest annual moves came in 2015 and 2018: Capital Leases fell 23.0% in 2015, then tumbled 84.94% in 2018.
- Over 5 years, Capital Leases stood at $11126.0 in 2014, then declined by 28.32% to $7975.0 in 2015, then plunged by 34.18% to $5249.0 in 2016, then slumped by 57.84% to $2213.0 in 2017, then tumbled by 74.33% to $568.0 in 2018.
- According to Business Quant data, Capital Leases over the past three periods registered $568.0, $1402.0, and $2213.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cellectar Biosciences | 6.73 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 568.00 |
| Mar 31, 2018 | 1,402.00 |
| Dec 31, 2017 | 2,213.00 |
| Sep 30, 2017 | 3,261.00 |
| Jun 30, 2017 | 3,772.00 |
| Mar 31, 2017 | 4,520.00 |
| Dec 31, 2016 | 5,249.00 |
| Sep 30, 2016 | 5,958.00 |
| Jun 30, 2016 | 6,649.00 |
| Mar 31, 2016 | 7,321.00 |
| Dec 31, 2015 | 7,975.00 |
| Sep 30, 2015 | 8,612.00 |
| Jun 30, 2015 | 9,233.00 |
| Mar 31, 2015 | 9,836.00 |
| Dec 31, 2014 | 11,126.00 |
| Sep 30, 2014 | 11,184.00 |
| Jun 30, 2013 | 431.00 |
| Mar 31, 2013 | 1,068.00 |
| Dec 31, 2012 | 1,694.00 |
| Sep 30, 2012 | 2,309.00 |